Karin Kast

10PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsRadiation therapyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 04, 2025
Breast Density Changes after Risk-Reducing Salpingo-oophorectomy in Women with a Pathogenic Germline Variant in BRCA1 or BRCA2.

Elizabeth A Loehrer, Frederieke H van der Baan, Thea M Mooij

|Feb 12, 2024
Treatment in Certified Breast Cancer Centers Improves Chances of Survival of Patients with Breast Cancer: Evidence Based on Health Care Data from the WiZen Study.

Olaf Schoffer, Pauline Wimberger, Michael Gerken

|Jan 17, 2024
Phenotype analysis of families with TP53 germline variants at the Center for Familial Breast and Ovarian Cancer, Cologne.

K Kast, K Rhiem, M Larsen

|Jun 27, 2023
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.

Mark van Barele, Delal Akdeniz, Bernadette A M Heemskerk-Gerritsen

|Jan 20, 2022
Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits.

Lieske H Schrijver, Thea M Mooij, Anouk Pijpe

|Sep 27, 2021
Breast cancer characteristics and surgery among women with Li-Fraumeni syndrome in Germany-A retrospective cohort study.

Nathalie Rippinger, Christine Fischer, Hans-Peter Sinn

Pageof 2

Frequent Collaborators

3 joint publications

Douglas F Easton

3 joint publications

Christoph Engel

2 joint publications

Maartje J Hooning

2 joint publications

Marjanka K Schmidt